UNCOVERING HOSPITALIZATION HIDDEN COSTS OF QUALITY FOR DENGUE FEVER PATIENTS: A CASE OF A PRIVATE HOSPITAL IN INDONESIA
National Health Insurance, a public health insurance currently used in Indonesia, is created with the aim of effective and efficient quality health services for the community and providers of health facilities, but on the one hand it still has the potential to cause real costs for hospitals as found in the case of hospitalization of patients with dengue fever. Basically, dengue fever is included in the category of tropical infectious diseases and in its handling falls into the non-surgical category, but the reality in the case of this disease provides a significant negative difference for the hospital, in contrast to previous studies which state that special cases surgery gives a lot of real costs to hospitals. Details of treatment costs that can be concluded from patients admitted to the hospital until the patient returns home with the approval of the doctor in cases of dengue fever include: (1) inpatient room, (2) examination of emergency room / outpatient clinic, (3) general practitioner visits, (4 ) specialist visits, (5) drugs, (6) injection drugs, (7) intravenous fluids, (8) use of ingredients, (9) room actions, (10) laboratory examinations, and (11) administration. The research method used is descriptive qualitative. The data used came from claims files and medical records of JKN-BPJS dengue fever patients in Sinar Kasih Hospital Purwokerto for the period of January 1, 2019 until March 30, 2019. The sampling technique uses total sampling, with 60 subjects after going through the exclusion process. All data were observed and recorded on the observation sheet, then analysed data using descriptive statistical analysis. The results of the study explain that the biggest cause of over cost in this case is hospitalization and laboratory examination.
Keywords: cost of quality, hidden cost, national health insurance, inpatient, dengue fever.
Agboadoa G, Peters J dan Donkin L. 2012.Factors influencing the length of stay of hospital stay among patients resident in blackpool admitted with COPD: a cross sectional study. Bio Medical Journal. 2. Ambarriani AS. 2014. Hospital financial performance in the indonesian national health insurance era. Review of Integrative Business and Economics Research. 4(1):121-133.
Annavi, Nugrahini Dian. 2011. Pengaruh Kode Tindakan Medis Operatif Terhadap Biaya Pelayanan Kesehatan Pada Sistem Pembayaran INA-CBG Di Bangsal Bedah RSUP Dr Sardjito Yogyakarta. Universitas Muhammadiyah Surakarta.
Campanella, J. Principles of Quality Costs. New York: ASQC Quality Press, 1990.
Chang L dan Lan YW. 2010. Has the national insurance scheme improved hospital efficiency in taiwan ? identifying factors that affects its efficiency. African Journal of Business Management 4 (17):3752-3760
Cook K, Dranove D dan Sfekas A. 2009. Does major illness cause financial catastrophe?.Health Services Research. 45(2):418-434.
Eisenhardt, K. M., & Graebner, M. E. 2007. Theory building from cases: Opportunities and challenges. Academy of Management Journal, 50 (1), 25-32.
Harrington, H. J. Poor-Quality Cost. New York : ASCQ Quality Press, 1987.
H. R. Ali, S.E. Glont, F. M. Blows, et al., 2015. PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes, Ann. Oncol. 26 (7) 1488 – 1493.
Ministry of Health of the Republic of Indonesia. 2013. Regulation of the Minister of Health of the Republic of Indonesia Number 69 of 2013 concerning Standards for Health Service Rates at First-Level Health Facilities and Advanced Health Facilities in the Implementation of Health Insurance Programs.
Ministry of Health of the Republic of Indonesia. 2014. Minister of Health Regulation of the Republic of Indonesia Number 59 of 2014 concerning Standard of Health Service Rates at First-Level Health Facilities and Advanced Health Facilities in the Implementation of Health Insurance Programs.
Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103:117-28.
Medbery RL, Perez SD, Force SD , et al. Video-assisted thoracic surgery lobectomy cost variability: implications for bundled payment era. Ann Thorac Surg 2014; 97: 1686-92 [discussion: 1692-3].
Ornek T, Tor M, Altin R, Atalay F, Geredeli E, Soylu O dan Erboy F. 2012. Clinical factors affecting the direct cost of patients hospitalized with acute ehacerbation of chronic obstructive pulmonary disease. International Journal Medical Science. 9(40):285- 290.
Porter, ME. A strategy for health care reform-toward a value-based system. N Engl J Med 2009:361: 109-12.
Porter, ME. What is value in health care? N Engl J Med 2010; 363:2477-81.
Putra PRS, Indar dan Jafar N. 2014. Ability to pay dan catastrophic payment pada peserta pembayar mandiri bpjs kesehatan kota makassar. Jurnal Kesehatan, 4 (3 ): 283 – 290.
Puspandari DA, Mukti. AG dan Kusnanto H. 2015. Faktor- faktor yang mempengaruhi biaya obat pasien kanker payudara di rumah sakit di indonesia. Jurnal Kebijakan Kesehatan Indonesia. 4(3):24-35.
Rejeki, VM, Athik Nurwahyuni. Cost of treatment demam berdarah dengue (DBD) di rawat inap berdasarkan clinical pathway di RS X Jakarta. 2017. Jurnal ekonomi kesehatan Indonesia. Vol 2. No. 2. 66 – 73.
Sabharwal S, Carter AW, Rashid A, Darzi A, Reilly P, Gupte CM. Cost analysisof the surgical treatment of fractures of the proximal humerus: an evaluation of the determinants of cost and comparison of the institutional cost of treatment with the national costs. Bone Joint Journal. 2016: 98 B (2): 249 – 259.
Wei DH, Hawker GA, Jevsevar DS, Bozic KJ. Improving value in musculoskeletal care delivery: AOA critical issues. J Bone Joint Surg Am. 2015; 372(24): 2281 – 2283.
WHO-SEARO. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. Revised and expanded. New Delhi: World Health Organization; 2011.
World Health Organization. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. New edition. Geneva. 2009.
World Health Organization. Global strategy for dengue prevention and control 2012-2020. Geneva. 2012
- There are currently no refbacks.